USPTO serial 79281294
SIMPROVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 11, 2021
- Examiner
- MASON, JARED MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SIMPROVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Tokyo, JP
Tokyo, JP
Tokyo, JP
JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Holly M. Ford Lewis
Holly M. Ford Lewis Oliff PLCP.O. Box 320850Alexandria, VA 22320-4850UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for laboratory or research purposes, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemicals for use in industry and science; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical reagents for use in genetic research; nucleic acid-based reagents, other than for medical or veterinary purposes; chemical and biochemical preparations for industrial or scientific purposes, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes, namely, nucleic acids reagents, buffer solution, aqueous and non-aqueous solutions of alcohols, salts, distilled water, purified water, silica in powdered or granulated form, and magnetic particles in fluid form; chemical materials for reaction vessels for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; reagents and solvents for sample preparation for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical, biochemical and biotechnological products for preparation, purification, lysis, modification and manipulation of samples, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, including nucleic acids made from biological and biochemical sample material, for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; nucleic acid-based reagents for medical or veterinary use; diagnostic preparations for medical or veterinary purposes, namely, nucleic acids, marking reagents, buffer chemicals, aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols, salts, distilled water, purified water, and magnetic particles in fluid form; diagnostic preparations for medical or veterinary purposes, namely, materials for reaction vessels for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds; diagnostic preparations for medical or veterinary purposes, namely, chemical, biochemical and biotechnological products, and kits comprising products for medical or veterinary purposes, namely, chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, namely, nucleic acids for medical and veterinary medical purposes, for detecting pathogens, genetic information and conditions of the human body | ACTIVE | — |
| 009 | Downloadable computer software used for medical examinations and diagnoses; computer hardware for data processing for scientific research or medical purposes; downloadable computer software for data processing for scientific research or medical purposes; computer programs, recorded, for the analysis of biological samples or microorganisms for scientific, research, or medical purposes; computer programs, downloadable, for the analysis of biological samples or microorganisms for scientific, research, or medical purposes; laboratory experimental machines and apparatus for the analysis of biological samples or microorganisms for scientific research purposes; laboratory apparatus and instruments for the analysis of biological samples or microorganisms for scientific research purposes; laboratory apparatus and instruments, namely, gene amplifiers; laboratory devices for detecting genetic sequences; molecular probes for scientific purposes other than for medical or veterinary purposes | ACTIVE | — |
| 010 | Diagnostic apparatus for medical purposes for the analysis of biological samples; fully automated nucleic acid-based reading and analysis medical instrument for rapid diagnostic of infections and diseases at point-of-care for personalized healthcare; genetic testing apparatus for medical or veterinary diagnostic use; clinical and medical diagnostic instruments, namely, nucleic acid analyzer; biological sample collection devices in the nature of medical devices for obtaining body fluid samples; medical specimen cups; disposable devices for analysis of biological samples for medical purposes; molecular probes for medical and veterinary medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named SIMPROVA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 4, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 11, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 12, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 20, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 11, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 11, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 3, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 19, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jan 19, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Nov 21, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Sep 18, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 8, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 8, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 8, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 29, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 15, 2020 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jun 19, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 15, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 17, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 17, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 1, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |